Cosimo X

Gecko Governance is a pioneering solution that provides fund managers with real-time oversight of regulatory compliance and governance requirements. It enables managers to track which funds are on schedule and which compliance tasks remain outstanding, facilitating the scheduling and management of all end-to-end compliance activities. The platform incorporates blockchain technology to enhance the management of fund data related to anti-money laundering, operational due diligence, fund launches, and onboarding processes. Gecko Governance offers a suite of integrated products that improve operational efficiency, cost-effectiveness, and compliance security. Its features include a centralized dashboard for multi-client oversight, customizable front-end options, a "drag and drop" regulatory calendar, and independent verifiable audit trails for compliance. The company operates from locations in New York City, Ireland, and Sydney, Australia, catering to the needs of fund managers and financial regulators alike.

Gecko Governance is a pioneering solution that provides fund managers with real-time oversight of regulatory compliance and governance requirements. It enables managers to track which funds are on schedule and which compliance tasks remain outstanding, facilitating the scheduling and management of all end-to-end compliance activities. The platform incorporates blockchain technology to enhance the management of fund data related to anti-money laundering, operational due diligence, fund launches, and onboarding processes. Gecko Governance offers a suite of integrated products that improve operational efficiency, cost-effectiveness, and compliance security. Its features include a centralized dashboard for multi-client oversight, customizable front-end options, a "drag and drop" regulatory calendar, and independent verifiable audit trails for compliance. The company operates from locations in New York City, Ireland, and Sydney, Australia, catering to the needs of fund managers and financial regulators alike.

Nova Leah Ltd is a company that specializes in cybersecurity solutions for medical device manufacturers. Founded in 2015 and headquartered in Dundalk, Ireland, with an additional office in Boston, Massachusetts, it has developed SelectEvidence, a sophisticated risk analysis and treatment platform. This software assists manufacturers and healthcare providers in managing cybersecurity risks throughout the product life cycle by tracking vulnerabilities and ensuring compliance with security regulations. SelectEvidence also facilitates communication between manufacturers and hospitals through a fully traceable framework. The company provides 24/7 technical support, online training, and continuous software updates, reflecting its commitment to enhancing the security assurance of medical devices through knowledge development and collaboration.